Literature DB >> 7073951

Cimetidine and therapy of rodent tumours.

D Hannant, K James, R E Bolton, M D Robertson, I Milne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7073951      PMCID： PMC2010991          DOI： 10.1038/bjc.1982.98

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Cimetidine does not influence immunological parameters in man.

Authors:  R J ten Berge; B E de Pauw; J Smeulders; D J Wagener
Journal:  Clin Immunol Immunopathol       Date:  1981-10

2.  Cimetidine reduction of tumour formation in mice.

Authors:  R R Gifford; R M Ferguson; B V Voss
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

3.  Successful tumour immunotherapy with cimetidine in mice.

Authors:  M E Osband; D Hamilton; Y J Shen; E Cohen; M Shlesinger; P Lavin; A Brown; R McCaffrey
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

4.  Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors.

Authors:  B E Ogden; H R Hill
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

5.  A technique for the flow cytometric analysis of lymphocytes bearing histamine receptors.

Authors:  M E Osband; E B Cohen; R P McCaffrey; H M Shapiro
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

6.  Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.

Authors:  D Hannant; J G Bowen; M R Price; R W Baldwin
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

7.  Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.

Authors:  M F Woodruff; M P Inchley; N Dunbar
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640
  7 in total
  4 in total

1.  Role of histamine in the antitumour activity of endotoxin.

Authors:  N Bloksma; P van de Wiel; F Hofhuis; F Kuper; J Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 2.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun

3.  Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-11-26

4.  Effects of cimetidine and indomethacin on the growth of dimethylhydrazine-induced or transplanted intestinal cancers in the rat.

Authors:  A Caignard; M Martin; D Reisser; B Thomas; F Martin
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.